Dretzke J, Edlin R, Round J, Connock M, Hulme C, et al. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-a) inhibitors, adalimumab and infliximab, for Crohn’s disease. Health Technol Assess 2011;15(6).
Dretzke J, Barton P, Kaambwa B, Connock M, Uthman O, Bayliss S, Meads C. Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia. Health Technol Assess 2010;14(Suppl. 2):19–26
Dretzke J, Round J, Connock M, Tubeuf S, Pennant M, Fry-Smith A, Hulme C, McCabe C, Meads C. Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours .Health Technol Assess 2010;14(Suppl. 2):63–70
Dretzke J, Davenport C, Frew E, Barlow J, Stewart-Brown S, Bayliss S, Taylor RS, Sandercock J, Hyde C. The clinical effectiveness of different parenting programmes for children with conduct problems: a systematic review of randomised controlled trials. Child Adolesc Psychiatry Ment Health. 2009;3(1):7.
Roberts J, Huissoon A, Dretzke J, Wang D, Hyde C.A systematic review of the clinical effectiveness of acupuncture for allergic rhinitis. BMC Complement Altern Med. 2008;8:13.
Dretzke J, Burls A, Bayliss S, Sandercock J. The clinical effectiveness of pre-hospital intravenous fluid replacement in trauma patients without head injury: a systematic review. Trauma 2006;8:131-141
Dretzke J, Frew E, Davenport C, Barlow J, Stewart-Brown S, Sandercock J, Bayliss S, Raftery J, Hyde C, Taylor R. The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children. Health Technology Assessment 2005; 9 (50)
Dretzke J, Sandercock J, Bayliss S and Burls A. Clinical effectiveness and cost-effectiveness of pre-hospital intravenous fluids in trauma patients. Health Technol Assess 2004;8(23)